Search hospitals > New York > Brooklyn
SUNY Downstate Medical Center
Claim this profileBrooklyn, New York 11203
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Ovarian Cancer
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Adenocarcinoma
243 reported clinical trials
9 medical researchers
Summary
SUNY Downstate Medical Center is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Human Immunodeficiency Virus Infection, Adenocarcinoma and other specialties. SUNY Downstate Medical Center is involved with conducting 243 clinical trials across 360 conditions. There are 9 research doctors associated with this hospital, such as Jacob Aranda, MD, Michael D. Hogarty, Stephan A Kohlhoff, MD, and Ho, MD.Area of expertise
1Cancer
Global LeaderStage III
Stage II
Stage I
2Recurrence
Global LeaderStage III
BRCA2 positive
BRCA1 positive
Top PIs
Jacob Aranda, MDSUNY Downstate Medical Center4 years of reported clinical research
Studies Premature Birth
Studies Neonatal Sepsis
2 reported clinical trials
5 drugs studied
Michael D. HogartyChildren's Hospital of Philadelphia1 year of reported clinical research
Studies Ganglioneuroblastoma
Studies Neuroblastoma
2 reported clinical trials
3 drugs studied
Stephan A Kohlhoff, MDSUNY Downstate Medical Center6 years of reported clinical research
Studies Hearing Loss
Studies Sensorineural Hearing Loss
1 reported clinical trial
1 drug studied
Ho, MDSUNY Downstate Medical Center1 year of reported clinical research
Studies Sinusitis
Studies Nasal Polyps
1 reported clinical trial
1 drug studied
Clinical Trials running at SUNY Downstate Medical Center
Non-Small Cell Lung Cancer
Lung Cancer
Stroke
Neonatal Sepsis
Transient Ischemic Attack
Necrotizing Enterocolitis
ALK Gene Rearrangement
Ischemia
Ischemic Stroke
Irritable Bowel Syndrome
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at SUNY Downstate Medical Center?
SUNY Downstate Medical Center is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Human Immunodeficiency Virus Infection, Adenocarcinoma and other specialties. SUNY Downstate Medical Center is involved with conducting 243 clinical trials across 360 conditions. There are 9 research doctors associated with this hospital, such as Jacob Aranda, MD, Michael D. Hogarty, Stephan A Kohlhoff, MD, and Ho, MD.